Who is sponsoring NCT04919291?

NCT04919291 is sponsored by Taipei Nobel Eye Clinic.

What condition does NCT04919291 study?

NCT04919291 studies Keratomileusis, Laser In Situ, Contrast Sensitivity.

What drugs are being tested in NCT04919291?

Interventions: Topoguided LASIK, Wavefront optimized LASIK.

What is the status of NCT04919291?

NCT04919291 is currently COMPLETED.

Last reviewed 2021-06-09 · How we verify

Direct Comparison of TG and WFO LASIK

NCT04919291 NA COMPLETED

To compare the efficacy to different profiles, direct head-to-head studies had been conducted. In one previous review study revealed that TG LASIK provided patient with better uncorrected visual acuity (UCVA) than WFO LASIK and WFG LASIK. In recent previous contralateral eye studies also showed that TG LASIK induced less postoperative higher-order aberration than WFO LASIK. However, these studies included only low-to-moderate myopia patients, for patients with high myopia (spherical equivalent \> 6D), the effect of TG LASIK comparing with WFO LASIK had not been reported before. The aim of our study is to analyze and compare the visual performance of TG LASIK and WFO LASIK in high myopia and low-to-moderate myopia patients, , particularly UCVA, corrected distance visual acuity (CDVA), contrast sensitivity (CS), and wavefront aberration.

Details

Lead sponsor	Taipei Nobel Eye Clinic
Phase	NA
Status	COMPLETED
Enrolment	21
Start date	Thu Sep 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Jun 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Keratomileusis, Laser In Situ
Contrast Sensitivity

Interventions

Topoguided LASIK
Wavefront optimized LASIK

Countries

Taiwan